Coy, Shannon
Wang, Shu
Stopka, Sylwia A.
Lin, Jia-Ren
Yapp, Clarence http://orcid.org/0000-0003-1144-5710
Ritch, Cecily C. http://orcid.org/0000-0001-7651-0419
Salhi, Lisa http://orcid.org/0000-0003-4654-9552
Baker, Gregory J. http://orcid.org/0000-0002-5196-3961
Rashid, Rumana
Baquer, Gerard http://orcid.org/0000-0002-4433-4972
Regan, Michael
Khadka, Prasidda http://orcid.org/0000-0002-3732-7600
Cole, Kristina A.
Hwang, Jaeho
Wen, Patrick Y.
Bandopadhayay, Pratiti http://orcid.org/0000-0002-4175-4760
Santi, Mariarita
De Raedt, Thomas
Ligon, Keith L. http://orcid.org/0000-0002-7733-600X
Agar, Nathalie Y. R. http://orcid.org/0000-0003-3149-3146
Sorger, Peter K. http://orcid.org/0000-0002-3364-1838
Touat, Mehdi http://orcid.org/0000-0002-5910-7799
Santagata, Sandro http://orcid.org/0000-0002-7528-9668
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM007748, T32-GM008313, T32-GM008208)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (T32-EB025823, P41-EB028741)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01-CA188288, R01-CA219943, P01-CA163205, U54-CA210180, U54-CA225088, U54-CA225088, P30-CA06516)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
National Brain Tumor Society (NBTS) and Accelerate Brain Cancer Cure (ABC2).
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
Capital Award from the Massachusetts Life Sciences Center
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Ludwig Center at Harvard
INCa, Fondation ARC and Ligue grant INCa-ARC-LIGUE_ID_16280
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (U2C-DK119886)
Article History
Received: 20 July 2021
Accepted: 29 July 2022
First Online: 16 August 2022
Competing interests
: M.T. has a consulting or advisory role with Agios Pharmaceutical, Integragen, and Taiho Oncology, and research funding from Sanofi. P.K.S. is a member of the SAB or BOD member of Applied Biomath, RareCyte Inc., and Glencoe Software; P.K.S. is also a member of the NanoString SAB and a consultant for Montai Health and Merck. In the last five years the Sorger lab has received research funding from Novartis and Merck. KLL is supported by Eli Lilly and BMS, consults for BMS, Integragen, Travera LLC, is on the SAB of Integragen and Rarecyte, and holds equity in Travera LLC. P.B. receives grant funding from Novartis Institute of Biomedical Research and Deerfield, and consults for QED Therapeutics, for unrelated projects. P.Y.W. has research support from Agios, Astra Zeneca, Medimmune, Celgene, Eli Lilly, Genentech, Roche, Kazia, MediciNova, Merck, Novartis, Nuvation Bio, Chimerix, Vascular Biogenics, and VBI Vaccines. P.W. is on the advisory boards of Agios, Astra Zeneca, Black Diamond, Boston Pharmaceuticals, Chimerix, CNS Pharmaceuticals, Elevate Bio, Imvax, Karyopharm, Merck, Mundipharma, Novocure, Novartis, Nuvation Bio, Prelude Therapeutics, Vascular Biogenics, VBI Vaccines, Voyager, and QED. RareCyte manufactured instruments used for tissue imaging and Glencoe developed the OMERO Database used for image informatics. P.K.S. and S.S. declare that none of these relationships have influenced the content of this manuscript. The remaining authors declare no competing interests.